Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074) (NCT04481191) | Merck Sharp & Dohme LLC | 2020-08-25 |
Track Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9 automatically
Every clearance here is in the API, with alerts when new ones post.